Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ETON
ETON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ETON News
Analysis of Biotech Companies' Stock Performance
2d ago
NASDAQ.COM
Eton Secures Exclusive U.S. Rights for IMPAVIDO Launch in 2026
May 20 2026
NASDAQ.COM
Eton Secures U.S. Commercialization Rights for IMPAVIDO®
May 19 2026
Newsfilter
Eton Pharmaceuticals Reports Record Sales and Raises Revenue Guidance
May 15 2026
Yahoo Finance
Eton Pharmaceuticals Reports Record Q1 2026 Earnings and Raises Revenue Guidance
May 15 2026
seekingalpha
Eton Pharmaceuticals Q1 Earnings Announcement Scheduled
May 13 2026
seekingalpha
Eton Pharmaceuticals to Report Q1 2026 Financial Results on May 14
May 04 2026
Newsfilter
Eton Pharmaceuticals CFO Departure Causes Stock Decline
Apr 16 2026
seekingalpha
Eton Pharmaceuticals Appoints New EVP of Finance
Apr 16 2026
NASDAQ.COM
Eton Pharmaceuticals Stock Trend Analysis
Mar 23 2026
NASDAQ.COM
Eton Pharma (ETON) Earnings Call Transcript
Mar 19 2026
NASDAQ.COM
Eton Pharmaceuticals Q4 Earnings Beat Expectations with Strong Revenue Growth
Mar 19 2026
seekingalpha
Eton Pharmaceuticals to Announce Q4 Earnings on March 19
Mar 18 2026
seekingalpha
Eton Pharmaceuticals Secures U.S. Rights for Hemangeol Commercialization
Mar 04 2026
NASDAQ.COM
Eton Pharmaceuticals to Report Q4 and Full Year 2025 Financial Results
Mar 03 2026
Newsfilter
Eton Secures U.S. Commercialization Rights for HEMANGEOL®
Mar 02 2026
Newsfilter
Show More News
